Related Experiment Videos

Macrophage activities in sarcoma 180-bearing mice and EL4-bearing mice

Gan
|February 1, 1982
PubMed

Insights

Macrophage immune functions like chemotaxis and digestion are impaired early in tumor-bearing mice. Later, macrophage enhancement activity declines, suggesting tumor-derived factors affect different macrophage types sequentially.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Biology

Background:

  • Macrophages play a crucial role in immune responses against tumors.
  • Tumor progression can significantly alter macrophage function.
  • Understanding these alterations is key to developing effective cancer immunotherapies.

Purpose of the Study:

  • To investigate the impact of tumor growth on various macrophage activities.
  • To differentiate the effects on different macrophage populations (Ia-negative and Ia-positive).
  • To identify potential mechanisms by which tumors suppress macrophage functions.

Main Methods:

  • Comparison of macrophage activities (chemotaxis, digestion, engulfment, and enhancement) in tumor-bearing mice (Sarcoma 180 and EL4) versus normal mice.
  • Assessment of O2- production via chemiluminescence for digestive activity.
  • Evaluation of blastogenic response of spleen lymphocytes to lipopolysaccharide for enhancement activity.

Main Results:

  • Macrophage chemotactic and digestive activities were reduced early in both slow-growing (Sarcoma 180) and rapid-growing (EL4) tumor models.
  • Engulfment activity remained largely unaffected until advanced tumor stages.
  • Macrophage enhancement activity was preserved initially but declined in later stages of tumor growth.

Conclusions:

  • Tumor-bearing hosts exhibit a general depression of Ia-negative macrophage activities early on.
  • Later stages show depression of Ia-positive macrophage activities, potentially mediated by tumor-secreted factors.
  • These findings highlight a sequential impairment of macrophage functions during tumor development.

Related Concept Videos